A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

NCT06780449 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Cagrilintide
DRUG: Semaglutide
DRUG: Placebo cagrilintide
DRUG: Placebo semaglutide

Sponsor

Novo Nordisk A/S